NLRP3 and endothelial dysfunction: TMAO also induces endothelial dysfunction by disrupting junction proteins, activating the NLRP3 inflammasome to release high-mobility group box 1 protein (HMGB1), and altering endothelial permeability (Singh et al., 2019).